US EditionPublished • loading... • Updated
Congruence secures $39.5m to advance small molecule correctors pipeline
Summary by Pharmaceutical-technology.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
Verdict Hospital+2 Reposted by 2 other sources
Congruence secures $39.5m to advance small molecule correctors pipeline
Congruence Therapeutics has completed a $39.5m financing round to advance its portfolio of small molecule correctors into the clinic.The post Congruence secures $39.5m to advance small molecule correctors pipeline appeared first on Hospital Management.
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium